《大行》浦銀國際列出7月南向資金淨流入前20大的港股名單(表)
浦銀國際發表報告,列出7月南向資金淨流入前20大的港股名單:
股份│7月港股通淨流入
比亞迪(01211.HK)│167.8億元
建行(00939.HK)│134.1億元
中芯(00981.HK)│78.3億元
美團(03690.HK)│74.2億元
國壽(02628.HK)│73.6億元
中國平安(02318.HK)│33.9億元
國泰海通(02611.HK)│32.3億元
中信証券(06030.HK)│31.9億元
信達生物(01801.HK)│29.4億元
港交所(00388.HK)│29.1億元
眾安在線(06060.HK)│28.2億元
中生製藥(01177.HK)│26億元
中石化(00386.HK)│23.4億元
地平線機器人-W(09660.HK)│23.2億元
理想汽車-W(02015.HK)│22.7億元
中國銀河(06881.HK)│21.1億元
百濟神州(06160.HK)│20.3億元
中銀香港(02388.HK)│20.2億元
健康之路(02587.HK)│19.9億元
快手-W(01024.HK)│19.4億元
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.